Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 29,730Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 23PUMA BIOTECH

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

NERATINIB MALEATE

US Patent Number : 7982043

Drug Substance Claim :

Drug Product Claim :

Application Number : 208051

Patent Use Code : U-2043

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-10-08

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

NERATINIB MALEATE

US Patent Number : 8518446

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208051

Patent Use Code : U-2043

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-11-20

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

NERATINIB MALEATE

US Patent Number : 10035788

Drug Substance Claim :

Drug Product Claim :

Application Number : 208051

Patent Use Code : U-2043

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-10-15

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

NERATINIB MALEATE

US Patent Number : 8790708

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208051

Patent Use Code : U-2043

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-11-05

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

NERATINIB MALEATE

US Patent Number : 9211291

Drug Substance Claim :

Drug Product Claim :

Application Number : 208051

Patent Use Code : U-2043

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-03-24

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

NERATINIB MALEATE

US Patent Number : 9630946

Drug Substance Claim :

Drug Product Claim :

Application Number : 208051

Patent Use Code : U-2043

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-10-15

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

NERATINIB MALEATE

US Patent Number : 7982043

Drug Substance Claim :

Drug Product Claim :

Application Number : 208051

Patent Use Code : U-3047

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-10-08

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

NERATINIB MALEATE

US Patent Number : 7982043

Drug Substance Claim :

Drug Product Claim :

Application Number : 208051

Patent Use Code : U-3097

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-10-08

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

NERATINIB MALEATE

US Patent Number : 8790708

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208051

Patent Use Code : U-3097

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-11-05

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

NERATINIB MALEATE

US Patent Number : 8790708

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208051

Patent Use Code : U-3047

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-11-05

blank